MDS
Clinical trials for MDS explained in plain language.
Never miss a new study
Get alerted when new MDS trials appear
Sign up with your email to follow new studies for MDS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug LYT-200 tested in patients with relapsed blood cancers
Disease control CompletedThis early-stage study tested a new drug called LYT-200 in 101 adults whose acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) had returned or stopped responding to treatment. The main goal was to check the drug's safety and find the right dose. Researchers …
Matched conditions: MDS
Phase: PHASE1 • Sponsor: PureTech • Aim: Disease control
Last updated May 17, 2026 04:24 UTC
-
Pill could replace shots for MDS patients, cutting hospital trips
Disease control CompletedThis study tested an oral chemotherapy pill (CC-486) in 11 older adults with higher-risk myelodysplastic syndromes (MDS) who had already responded to injected azacitidine. The goal was to see if switching to the pill could maintain their response and improve quality of life by re…
Matched conditions: MDS
Phase: PHASE2 • Sponsor: University of Florence • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New method spots returning cancer before symptoms appear
Knowledge-focused CompletedThis study looked at 308 people with MDS (a bone marrow disorder) who had a stem cell transplant. Researchers tracked unique genetic mutations in their blood and bone marrow to see if they could detect the cancer coming back earlier than standard tests. The goal was to find the l…
Matched conditions: MDS
Sponsor: Nordic MDS Group • Aim: Knowledge-focused
Last updated May 17, 2026 04:12 UTC